Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.705 USD | -0.66% | -15.55% | +24.18% |
Mar. 14 | Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.18% | 126M | |
-3.08% | 104B | |
+0.18% | 97.42B | |
+1.02% | 22.2B | |
-18.21% | 21.23B | |
-11.11% | 18.33B | |
-42.83% | 16.35B | |
-17.18% | 15.06B | |
+3.50% | 13.98B | |
+29.20% | 11.66B |
- Stock Market
- Equities
- VXRT Stock
- News Vaxart, Inc.
- Vaxart : Oral COVID-19 Vaccine Points to Cross-Reactivity vs Other Coronaviruses -- Stock Jumps 15% After-Hours